drugset / Trial / NCT01446640

Mesenchymal Stem Cells Transplantation to Patients With Spinal Cord Injury

NCT01446640

NaSingle-groupOpen-labelTreatment

Summary

The study is a phase I/II trial designed to establish the safety and efficacy of intravenous combined with intrathecal administration of autologous bone marrow derived mesenchymal stem cells to patients with spinal cord injury.

Timeline

Start
2011-10
Primary completion
2013-06
Completion
2014-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesenchymal stem cell Cell therapy 1e+06 cells/kg Intravenous

Indications